Skip to main content
SpringerLink
Log in

A Rational Approach to Treating Hypercholesterolaemia in Children

Weighing the Risks and Benefits

  • Review Articles
  • Risk-Benefit Assessment
  • Published:
Drug Safety Aims and scope Submit manuscript

Summary

Because atherosclerosis is a continuous process throughout life, expert panels have suggested guidelines to reduce the risk of cardiovascular disease, starting from childhood. The guidelines focus on population-based measures and on treating hypercholesterolaemia in individual children.

Low-fat diets in children have been widely debated. There is little evidence that growth is stunted or that nutritional deficiencies arise if the energy that is lost by limiting fat intake is substituted with other nutrients. Dietary fibre, plant sterols and fish oils have been used to modify lipid levels in children; however, the efficacy of these dietary adjuncts is limited.

Bile acid-binding resins are the only approved drugs to lower cholesterol levels in children and appear to be well tolerated. However, compliance with resins is low because of unpalatability, so low dosages are preferred and vitamin supplementation is prudent. Data on HMG CoA reductase inhibitors and fibrates are insufficient to recommend these drugs at present.

Drug treatment should be restricted to children who are at exceptionally high risk of disease, usually those with genetic dyslipidaemias.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Holman RL. Atherosclerosis: a paediatric nutrition problem. Am J Clin Nutr 1961; 9: 565–9

    PubMed  CAS  Google Scholar 

  2. Kwiterovich Jr PO. Biochemical, clinical, epidemiologic, genetic, and pathologic data in the pediatric age group relevant to the cholesterol hypothesis. Pediatrics 1986; 78: 349–62

    PubMed  Google Scholar 

  3. Williams CL, Wynder EL, editors. Hyperlipidemia in childhood and the development of atherosclerosis. Ann N Y Acad Sci 1991; 623: 1–480

    Google Scholar 

  4. Strong JP, Malcom GT, Oalmann MC and the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Environmental and genetic risk factors in early human atherogenesis: lessons from the PDAY study. Pathol Int 1995; 45: 403–8

    PubMed  CAS  Google Scholar 

  5. National Cholesterol Education Program. Report of the Expert Panel on blood cholesterol levels in children and adolescents. Pediatrics 1992; 89: 525–84

    Google Scholar 

  6. European Atherosclerosis Society International Task Force for Prevention of Coronary Heart Disease. Prevention of coronary heart disease: scientific background and new clinical guidelines. Nutr Metab Cardiovasc Dis 1992; 2: 113–56

    Google Scholar 

  7. Åkerblom HK, Chandra RK, Franklin FA, et al. Conclusions, guidelines and recommendations from the IUNS/WHO workshop: nutrition in the pediatric age group and later cardiovascular disease. J Am Coll Nutr 1992; 11 Suppl. S: 1S–2S

    PubMed  Google Scholar 

  8. American Academy of Pediatrics. Committee on Nutrition: statement on cholesterol. Pediatrics 1992; 90: 469–73

    Google Scholar 

  9. ESPGAN Committee on Nutrition. Committee report: childhood diet and prevention of coronary heart disease. J Pediatr Gastroenterol Nutr 1994; 19: 261–9

    Google Scholar 

  10. Zlotkin SH. A review of the Canadian ‘Nutrition recommendations update: dietary fat and children’. J Nutr 1996; 126: 1022S–7S

    PubMed  CAS  Google Scholar 

  11. Wray R, Neil HAW, Rees JAE. Screening for hyperlipidaemia in childhood: recommendations of the British Hyperlipidaemia Association. J R Coll Physicians London 1996; 30: 115–8

    CAS  Google Scholar 

  12. Ose L, Tonstad S. The detection and management of dyslipidaemia in children and adolescents. Acta Paediatr 1995; 84: 1213–5

    PubMed  CAS  Google Scholar 

  13. Skovby F, Dyerberg J, Færgeman O, et al. Hyperlipidaemi hos børn. Ugeskrift for Laeger 1993; 155: 810–4

    PubMed  CAS  Google Scholar 

  14. Newman TB, Browner WS, Hulley SB. The case against childhood cholesterol screening. JAMA 1990; 264: 3039–43

    PubMed  CAS  Google Scholar 

  15. Olson RE. The dietary recommendations of the American Academy of Pediatrics. Am J Clin Nutr 1995; 61: 271–3

    PubMed  CAS  Google Scholar 

  16. Gillman MW, Lannon CM. Screening for hypercholesterolemia in children: the missing links. Ann Epidemiol 1991; 1: 559–65

    PubMed  CAS  Google Scholar 

  17. Zlotkin SH. Reducing dietary intake of fat and cholesterol in children |letter|. JAMA 1995; 274: 1423–4

    PubMed  CAS  Google Scholar 

  18. Newman TB, Garber AM, Holtzman NA, et al. Problems with the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Arch Pediatr Adolesc Med 1995; 149: 241–7

    PubMed  CAS  Google Scholar 

  19. Weidman WH. Position statement: the ‘cons’ of cholesterol screening in children. J Am Coll Nutr 1992; 11 Suppl. S: 18S–9S

    PubMed  Google Scholar 

  20. Holtzman NA. The great god cholesterol. Pediatrics 1991; 87: 943–5

    PubMed  CAS  Google Scholar 

  21. Lauer RM, Clarke WR. Use of cholesterol measurements in childhood for the prediction of adult hypercholesterolemia: the Muscatine Study. JAMA 1990: 264: 3034–8

    PubMed  CAS  Google Scholar 

  22. Griffin TC, Christoffel KK, Binns HJ, et al. Family history evaluation as a predictive screen for childhood hypercholesterolemia. Pediatrics 1989; 84: 365–73

    PubMed  CAS  Google Scholar 

  23. Dennison BA, Kikuchi DA, Srinivasan SR, et al. Parental history of cardiovascular disease as an indication for screening for lipoprotein abnormalities in children. J Pediatr 1989; 115: 186–94

    PubMed  CAS  Google Scholar 

  24. Shea S, Basch CE, Irigoyen M, et al. Failure of family history to predict high blood cholesterol among Hispanic preschool children. Prev Med 1990; 19: 443–55

    PubMed  CAS  Google Scholar 

  25. Steiner NJ, Neinstein LS, Pennbridge J. Hypercholesterolemia in adolescents: effectiveness of screening strategies based on selected risk factors. Pediatrics 1991; 88: 269–75

    PubMed  CAS  Google Scholar 

  26. Dennison BA, Jenkins PL, Pearson TA. Challenges to implementing the current pediatric cholesterol screening guidelines into practice. Pediatrics 1994; 94: 296–302

    PubMed  CAS  Google Scholar 

  27. Primrose ED, Savage JM, Boreham CA, et al. Cholesterol screening and family history of vascular disease. Arch Dis Child 1994; 71: 239–42

    PubMed  CAS  Google Scholar 

  28. Rona RJ, Qureshi S, Chinn S. Factors related to total cholesterol and blood pressure in British 9-year-olds. J Epidemiol Community Health 1996; 50: 512–8

    PubMed  CAS  Google Scholar 

  29. Resnicow K, Cross D. Are parents’ self-reported total cholesterol levels useful in identifying children with hyperlipidemia? An examination of current guidelines. Pediatrics 1993; 92: 347–54

    PubMed  CAS  Google Scholar 

  30. Stein EA. Guidelines and methods for assessing pediatric hyperlipidemia. Curr Opin Lipidol 1992; 3: 395–8

    Google Scholar 

  31. Shepherd J, Cobbe SM, Ford I, for the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995; 333: 1301–7

    PubMed  CAS  Google Scholar 

  32. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383–9

    Google Scholar 

  33. Levine GN, Keaney Jr JF, Vita JA. Cholesterol reduction in cardiovascular disease: clinical benefits and possible mechanisms. N Engl J Med 1995; 332: 512–21

    PubMed  CAS  Google Scholar 

  34. Leung W-H, Lau C-P, Wong C-K. Beneficial effect of cholesterol-lowering on coronary endothelium-dependent relaxation in hypercholesterolaemic patients. Lancet 1993; 341: 1496–500

    PubMed  CAS  Google Scholar 

  35. Porkka KVK, Viikari JSA, Taimela S, et al. Tracking and predictiveness of serum lipid and lipoprotein measurements in childhood: a 12-year follow-up. Am J Epidemiol 1994; 140: 1096–109

    PubMed  CAS  Google Scholar 

  36. Labarthe DR. Coronary risk factors in childhood. In: Marmot M, Elliott P, editors. Coronary heart disease epidemiology: from aetiology to public health. Oxford: Oxford University Press, 1992: 92–102

    Google Scholar 

  37. Rifai N, Neufeld E, Ahlstrom P, et al. Failure of current guidelines for cholesterol screening in urban African-American adolescents. Pediatrics 1996; 98: 383–8

    PubMed  CAS  Google Scholar 

  38. Neil HAW, Mant D. Cholesterol screening and life assurance. BMJ 1991; 302: 891–3

    PubMed  CAS  Google Scholar 

  39. Rosenthal SL, Knauer-Black S, Stahl MP, et al. The psychological functioning of children with hypercholesterolemia and their families. Clin Pediatrics (Phila) 1993; 32: 135–41

    CAS  Google Scholar 

  40. Tonstad S. Familial hypercholesterolaemia: a pilot study of parents’ and children’s concerns. Acta Paediatr 1996; 85: 1307–13

    PubMed  CAS  Google Scholar 

  41. Tonstad S, Nøvik TS, Vandvik IH. Psychosocial function during treatment for familial hypercholesterolemia. Pediatrics 1996; 98: 249–55

    PubMed  CAS  Google Scholar 

  42. Tonstad S, Sivertsen S. Food dislikes and dietary intake in children with familial hypercholesterolemia and controls. Scand J Nutr 1996; 40: 146–50

    Google Scholar 

  43. Kennedy E, Goldberg J. What are American children eating? Implications for public policy. Nutr Rev 1995; 53: 111–26

    PubMed  CAS  Google Scholar 

  44. Samuelson G, Bratteby L-E, Enghardt H, et al. Food habits and energy and nutrient intake in Swedish adolescents approaching the year 2000. Acta Paediatr Scand 1996; 415 Suppl.: 1–20

    CAS  Google Scholar 

  45. Frost Andersen L, Nes M, Sandstad B, et al. Dietary intake among Norwegian adolescents. Eur J Clin Nutr 1995; 49: 555–64

    Google Scholar 

  46. Michaelsen KF, Jørgensen MH. Dietary fat content and energy density during infancy and childhood: the effect on energy intake and growth. Eur J Clin Nutr 1995; 49: 467–83

    PubMed  CAS  Google Scholar 

  47. Writing Group for the DISC Collaborative Research Group. Efficacy and safety of lowering dietary intake of fat and cholesterol in children with elevated low-density lipoprotein cholesterol: the Dietary Intervention Study in Children (DISC). JAMA 1995; 273: 1429–35

    Google Scholar 

  48. Lifshitz F, Moses N. Growth failure: a complication of dietary treatment of hypercholesterolemia. Am J Dis Child 1989; 143: 537–42

    PubMed  CAS  Google Scholar 

  49. Kleinman RE, Finberg LF, Klish WJ, et al. Dietary guidelines for children: US recommendations. J Nutr 1996; 126: 1028S–30S

    PubMed  CAS  Google Scholar 

  50. Kaplan RM, Toshima MT. Does a reduced fat diet cause retardation in child growth? Prev Med 1992; 21: 33–52

    PubMed  CAS  Google Scholar 

  51. Lifshitz F, Tarim O. Consideration about dietary fat restrictions for children. J Nutr 1996; 126: 1031S–41S

    PubMed  CAS  Google Scholar 

  52. Harper AE. Dietary guidelines in perspective. J Nutr 1996; 126: 1042S–8S

    PubMed  CAS  Google Scholar 

  53. Lapinleimu H, Viikari J, Jokinen E, et al. Prospective randomised trial in 1062 infants of diet low in saturated fat and cholesterol. Lancet 1995; 345: 471–6

    PubMed  CAS  Google Scholar 

  54. Mertz W, Tsui JC, Judd JT, et al. What are people really eating? The relation between energy intake derived from estimated diet records and intake determined to maintain body weight. Am J Clin Nutr 1991; 54: 291–5

    PubMed  CAS  Google Scholar 

  55. Hegsted DM. What are American children eating? Implications for public policy |letter|. Nutr Rev 1996; 5.4: 67

    Google Scholar 

  56. Friedman G, Goldberg SJ. An evaluation of the safety of a low-saturated-fat, low-cholesterol diet beginning in infancy. Pediatrics 1976; 58: 655–7

    PubMed  CAS  Google Scholar 

  57. Nicklas TA, Webber LS, Koschak ML, et al. Nutrient adequacy of low fat intakes for children: the Bogalusa Heart Study. Pediatrics 1992; 89: 221–8

    PubMed  CAS  Google Scholar 

  58. Vobecky JS, Vobecky J, Normand L. Risk and benefit of low fat intake in childhood. Ann Nutr Metab 1995; 39: 124–33

    PubMed  CAS  Google Scholar 

  59. Nicklas TA, Myers L, Farris RP, et al. Nutritional quality of a high carbohydrate diet as consumed by children: the Bogalusa Heart Study. J Nutr 1996; 126: 1382–8

    PubMed  CAS  Google Scholar 

  60. Tonstad S, Sivertsen M. Dietary adherence in familial hypercholesterolemia. Am J Clin Nutr. 1997; 65: 1018–26

    PubMed  CAS  Google Scholar 

  61. Tonstad S, Sivertsen M. Relationship between dietary fat and energy and micronutrient intake. Arch Dis Child. In press 62.

  62. McPherson RS, Nichaman MZ, Kohl HW, et al. Intake and food sources of dietary fat among schoolchildren in The Woodlands, Texas. Pediatrics 1990; 86: 520–6

    PubMed  CAS  Google Scholar 

  63. Ursin G, Ziegler RG, Subar AF, et al. Dietary patterns associated with a low-fat diet in the National Health Examination Follow-up Study: identification of potential confounders for epidemiologic analyses. Am J Epidemiol 1993; 137: 916–27

    PubMed  CAS  Google Scholar 

  64. Assouline L, Levy E, Feoli-Fonseca JC, et al. Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population. Pediatrics 1995; 96: 239–46

    PubMed  CAS  Google Scholar 

  65. Niinikoski H, Viikari J, Rönnemaa T, et al. Prospective randomized trial of low-saturated-fat, low-cholesterol diet during the first 3 years of life. Circulation 1996; 94: 1386–93

    PubMed  CAS  Google Scholar 

  66. Sanders T, Lynas J. Determinants of lipid and lipoprotein concentrations and the dietary management of hyperlipidaemia in childhood. In: Neil A, Rees A, Taylor C, editors. Hyperlipidaemia in childhood. London: Royal College of Physicians of London, 1996: 41–9

    Google Scholar 

  67. Connor WE, Connor SL. Importance of diet in the treatment of familial hypercholesterolemia. Am J Cardiol 1993; 72: 42D–53D

    PubMed  CAS  Google Scholar 

  68. Fernandes J, Dijkhuis-Stoffelsma R, Grooet PHE, et al. The effect of a virtually cholesterol-free, high-linoleic-acid vegetarian diet on serum lipoproteins of children with familial hypercholesterolemia (type II-A). Acta Paediatr Scand 1981; 70: 677–82

    PubMed  CAS  Google Scholar 

  69. Widhalm K, Brazda G, Schneider B, et al. Effect of soy protein diet versus standard low fat, low cholesterol diet on lipid and lipoprotein levels in children with familial or polygenic hypercholesterolemia. J Pediatr 1993; 123: 30–4

    PubMed  CAS  Google Scholar 

  70. Gaddi A, Descovich GC, Noseda G, et al. Hypercholesterolaemia treated by soybean protein diet. Arch Dis Child 1987; 62: 274–8

    PubMed  CAS  Google Scholar 

  71. Wolf G. High-fat, high-cholesterol diet raises plasma HDL cholesterol: studies on the mechanism of this effect. Nutr Rev 1996; 54: 34–5

    PubMed  CAS  Google Scholar 

  72. Porkka KVK, Raitakari OT. Serum lipoproteins in children and young adults: determinants and treatment strategies. Curr Opin Lipidol 1996; 7: 183–7

    PubMed  CAS  Google Scholar 

  73. Mietus-Snyder M, Baker AL, Neufeld EJ, et al. Effects of nutritional counselling on lipoprotein levels in a pediatric lipid clinic. Am J Dis Child 1993; 147: 378–81

    PubMed  CAS  Google Scholar 

  74. Mann J. Position statement: nutrition options when reducing saturated fat intake. J Am Coll Nutr 1992; 11 Suppl. S: 82S–3S

    PubMed  Google Scholar 

  75. Zavoral JH, Hannan P, Fields DJ, et al. The hypolipidemic effect of locust bean gum food products in familial hypercholesterolemic adults and children. Am J Clin Nutr 1983; 38: 285–94

    PubMed  CAS  Google Scholar 

  76. Gold K, Wong N, Tong A, et al. Serum apolipoprotein and lipid profile effects of an oat-bran-supplemented, low fat diet in children with elevated serum cholesterol. Ann N Y Acad Sci 1991; 623: 429–31

    PubMed  CAS  Google Scholar 

  77. Dennison BA, Levine DM. Randomized, double-blind, placebo-controlled, two-period crossover clinical trial of psyllium fiber in children with hypercholesterolemia. J Pediatr 1993; 123: 24–9

    PubMed  CAS  Google Scholar 

  78. Davidson MH, Dugan LD, Burns JH, et al. A psyllium-enriched cereal for the treatment of hypercholesterolemia in children: a controlled, double-blind, crossover study. Am J Clin Nutr 1996; 63: 96–102

    PubMed  CAS  Google Scholar 

  79. Becker M, Staab D, Von Bergmann K. Treatment of severe familial hypercholesterolemia in childhood with sitosterol and sitostanol. J Pediatr 1993; 122: 292–6

    PubMed  CAS  Google Scholar 

  80. Gylling H, Siimes MA, Miettinen TA. Sitostanol ester margarine in dietary treatment of children with familial hypercholesterolemia. J Lipid Res 1995; 36: 1807–12

    PubMed  CAS  Google Scholar 

  81. Goran A, Stankiewica H, Goldstein R, et al. Fish oil treatment of hyperlipidemia in children and adolescents receiving renal replacement therapy. Pediatrics 1991; 88: 265–8

    Google Scholar 

  82. Glueck CJ, Fallat RW, Tsang RC. Pediatrie familial type II hyperlipoproteinemia therapy with diet and cholestyramine resin. Pediatrics 1973; 52: 669–79

    PubMed  CAS  Google Scholar 

  83. West RJ, Lloyd JK. Use of cholestyramine in treatment of children with familial hypercholesterolaemia. Arch Dis Child 1973; 48: 370–4

    PubMed  CAS  Google Scholar 

  84. Wheeler KAH, West RJ, Lloyd JK, et al. Double-blind trial of bezafibrate in familial hypercholesteroalaemia. Arch Dis Child 1985; 60: 34–7

    PubMed  CAS  Google Scholar 

  85. Reihnér E, Angelin B, Rudling M, et al. Regulation of hepatic cholesterol metabolism in humans: stimulatory effects of cholestyramine on HMG-CoA reductase activity and low density lipoprotein receptor expression in gallstone patients. J Lipid Res 1990; 31: 2219–26

    PubMed  Google Scholar 

  86. Angelin B, Leijd B, Hultcrantz R, et al. Increased turnover of very low density lipoprotein triglyceride during treatment with cholestyramine in familial hypercholesterolaemia. J Intern Med 1990; 227: 201–6

    PubMed  CAS  Google Scholar 

  87. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA 1984; 251: 351–64

    Google Scholar 

  88. Cashin-Hemphill L, Mack WJ, Pogoda JM, et al. Beneficial effects of colestipol-niacin on coronary atherosclerosis. JAMA 1990; 264: 3013–7

    PubMed  CAS  Google Scholar 

  89. Dorr AE, Gundersen K, Schneider JC, et al. Colestipol hydrochloride in hypercholesterolemic patients: effect on serum cholesterol and mortality. J Chron Dis 1978; 31: 5–14

    PubMed  CAS  Google Scholar 

  90. Farah JR, Kwiterovich PO, Neill CA. Dose-effect relation of cholestyramine in children and young adults with familial hypercholesterolaemia. Lancet 1977; 1: 59–63

    PubMed  CAS  Google Scholar 

  91. West RJ, Lloyd JK. Long-term follow-up of children with familial hypercholesterolaemia treated with cholestyramine. Lancet 1980; 2: 873–5

    PubMed  CAS  Google Scholar 

  92. Groot PHE, Dijkhuis-Stoffelsma R, Grose WFA, et al. The effects of colestipol hydrochloride on serum lipoprotein lipid and apolipoprotein B and A-I concentrations in children heterozygous for familial hypercholesterolemia. Acta Paediatr Scand 1983; 72: 81–5

    PubMed  CAS  Google Scholar 

  93. Superko HR, Greenland P, Manchester RA, et al. Effectiveness of low-dose colestipol therapy in patients with moderate hypercholesterolemia. Am J Cardiol 1992; 70: 135–40

    PubMed  CAS  Google Scholar 

  94. Tonstad S, Knudtzon J, Sivertsen M, et al. Efficacy and safety of cholestyramine in peripubertal and prepubertal children with familial hypercholesterolemia. J Pediatr 1996; 129: 42–9

    PubMed  CAS  Google Scholar 

  95. Tonstad S, Sivertsen M, Aksnes L, et al. Low dose colestipol in adolescents with familial hypercholesterolemia. Arch Dis Child 1996; 74: 157–60

    PubMed  CAS  Google Scholar 

  96. Liacouras CA, Coates PM, Gallagher PR, et al. Use of cholestyramine in the treatment of children with familial combined hyperlipidemia. J Pediatr 1993; 122: 477–82

    PubMed  CAS  Google Scholar 

  97. Hansen D, Michaelsen KF, Skovby F. Growth during treatment of familial hypercholesterolemia. Acta Paediatr 1992; 81: 1023–5

    PubMed  CAS  Google Scholar 

  98. Koletzko B, Kupke I, Wendel U. Treatment of hypercholesterolemia in children and adolescents. Acta Paediatr 1992; 81: 682–5

    PubMed  CAS  Google Scholar 

  99. West RJ, Lloyd JK. The effect of cholestyramine on intestinal absorption. Gut 1975; 16: 93–8

    PubMed  CAS  Google Scholar 

  100. Tonstad S, Aksnes L. Fat soluble vitamin levels in familial hypercholesterolemia. J Pediatr 1997; 130: 274–80

    PubMed  CAS  Google Scholar 

  101. Tonstad S, Ose L. Colestipol tablets in adolescents with familial hypercholesterolaemia. Acta Paediatr 1996; 85: 1080–2

    PubMed  CAS  Google Scholar 

  102. Tonstad S, Bing RF, Frohlich J, et al. Effectiveness of colestipol tablets vs granules in patients with moderate to severe hypercholesterolaemia. Clin Drug Invest 1995; 10: 257–63

    CAS  Google Scholar 

  103. Ducobu J, Brasseur D, Chaudron JM, et al. Simvastatin use in children |letter|. Lancet 1992; 339: 1488

    PubMed  CAS  Google Scholar 

  104. Sinzinger H, Schmid P, Pirich CH, et al. Treatment of hypercholesterolaemia in children. Lancet 1992; 340: 548–9

    PubMed  CAS  Google Scholar 

  105. Sinzinger H, Mayr F, Schmid P, et al. Sleep disturbance and appetite loss after lovastatin. Lancet 1994; 343: 973

    PubMed  CAS  Google Scholar 

  106. Knipscheer HC, Boelen CCA, Kastelein JJP, et al. Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemia. Pediatr Res 1996; 39: 867–71

    PubMed  CAS  Google Scholar 

  107. Lambert M, Lupien P-J, Gagné C, et al. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Pediatrics 1996; 97: 619–28

    PubMed  CAS  Google Scholar 

  108. Illingworth DR. Drug therapy for hyperlipidaemia in childhood. In: Neil A, Rees A, Taylor C, editors. Hyperlipidaemia in childhood. London: Royal College of Physicians of London, 1996: 51–65

    Google Scholar 

  109. Steinmetz J, Morin C, Panek E, et al. Biological variations in hyperlipidemic children and adolescents treated with feno-fibrate. Clin Chim Acta 1981; 112: 43–53

    PubMed  Google Scholar 

  110. Colletti RB, Neufeld EJ, Roff NK, et al. Niacin treatment of hypercholesterolemia in children. Pediatrics 1993; 92: 78–82

    PubMed  CAS  Google Scholar 

  111. Kelder SH, Perry CL, Klepp Kl, et al. Longitudinal tracking of adolescent smoking, physical activity and food choice behaviors. Am J Public Health 1994; 84: 1121–6

    PubMed  CAS  Google Scholar 

  112. Diller PM, Huster GA, Leach AD, et al. Definition and application of the discretionary screening indicators according to the National Cholesterol Education Program for children and adolescents. J Pediatr 1995; 126: 345–52

    PubMed  CAS  Google Scholar 

  113. Goldstein JL, Hobbs HH, Brown MS. Familial hyper-cholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, et al., editors. The metabolic and molecular bases of inherited disease. 7th ed. New York: McGraw-Hill Inc., 1995: 1981–2030

    Google Scholar 

  114. Tonstad S, Joakimsen O, Stensland-Bugge E, et al. Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and controls. Arterioscler Thromb Vasc Biol 1996; 16: 984–91

    PubMed  CAS  Google Scholar 

  115. Sorensen KE, Celermajer DS, Georgakopoulos D, et al. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level. J Clin Invest 1994; 93: 50–5

    PubMed  CAS  Google Scholar 

  116. Hegele RA, Connelly PW, Cullen-Dean G. Elevated plasma lipoprotein(a) associated with abnormal stress thallium scans in children with familial hypercholesterolemia. Am J Cardiol 1993; 72: 402–6

    PubMed  CAS  Google Scholar 

  117. Lloyd JK. Cholesterol: should we screen all children or change the diet of all children. Acta Paediatr Scand 1991; 373 Suppl.: 66–72

    CAS  Google Scholar 

  118. Gillman MW. Screening for familial hypercholesterolemia in childhood. Am J Dis Child 1993; 147: 393–6

    PubMed  CAS  Google Scholar 

  119. Wray R, Neil A, Rees A. Hyperlipidaemia in childhood: a screening strategy. UK recommendations. In: Neil A, Rees A, Taylor C, editors. Hyperlipidaemia in childhood. London: Royal College of Physicians of London, 1996: 99–105

    Google Scholar 

  120. Fraser GE. Diet and coronary heart disease: beyond dietary fats and low-density-lipoprotein cholesterol. Am J Clin Nutr 1994; 59 Suppl.: 1117–23

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Preventive Cardiology, Ullevål Hospital, 0407, Oslo, Norway

    Serena Tonstad

Authors
  1. Serena Tonstad
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Serena Tonstad.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tonstad, S. A Rational Approach to Treating Hypercholesterolaemia in Children. Drug-Safety 16, 330–341 (1997). https://doi.org/10.2165/00002018-199716050-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199716050-00004

Keywords

Search

Navigation